Company: SXTPW
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065718
Chunk: 3

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Exhibit                                                                             
          4.1      Form of Series A-1 Warrant                                                          
          4.2      Form of Series A-2 Warrant                                                          
          4.3      Form of Pre-Funded Warrant                                                          
          4.4      Form of Placement Agent Warrant                                                     
         10.1      Form of Securities Purchase Agreement by and between the Company and the Investors  
         99.1      Press Release dated July 15, 2025                                                   
         99.2      Press Release dated July 16, 2025                                                   
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)         

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                           60 DEGREES PHARMACEUTICALS, INC.                                             
  Date: July 18, 2025      By:                                   /s/ Geoffrey Dow                       
                           Name:                                 Geoffrey Dow                           
                           Title:                                Chief Executive Officer and President